Production (Stage)
Rani Therapeutics Holdings, Inc.
RANI
$0.5289
-$0.031-5.54%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 2.93% | -26.05% | 26.25% | 26.85% | 10.62% |
| Total Depreciation and Amortization | 1.21% | 17.18% | 18.81% | 34.92% | 31.91% |
| Total Amortization of Deferred Charges | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Non-Cash Items | 63.93% | 141.12% | 71.49% | 41.86% | 24.44% |
| Change in Net Operating Assets | -97.59% | 62.14% | 24.07% | -93.56% | 155.04% |
| Cash from Operations | 13.33% | 30.64% | 41.20% | 26.60% | 22.64% |
| Capital Expenditure | -183.33% | 81.44% | 73.90% | 71.94% | 92.74% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 77.27% | -81.01% | -95.11% | 488.88% | 135.92% |
| Cash from Investing | 77.08% | -81.01% | -95.98% | 727.00% | 149.67% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -65.29% | 9,668.75% | 11,397.44% | 85.39% | -8.33% |
| Repurchase of Common Stock | -- | -- | 51.72% | -166.67% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -3,183.47% | 5,753.13% | 15,622.45% | 76.25% | 1,412.50% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 526.75% | -157.74% | 90.81% | 79.33% | 112.63% |